Funding for this research was provided by:
Limb Girdle Muscular Dystrophy 2i Research Fund (NA)
Pfizer, Inc. (NA)
Cure LGMD2I (NA)
Received: 11 February 2020
Accepted: 10 May 2020
First Online: 19 May 2020
Ethics approval and consent to participate
: The protocol for this study was approved by the Institutional Review Board Pre-review Committee at the Kennedy Krieger Institute and the Johns Hopkins Medicine Institutional Review Boards and performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments or comparable human subjects research standards. All participants provided written informed consent prior to their inclusion in the study. Personally identifiable information was omitted from the collected data prior to analysis.
: Not applicable.
: Funding for the overall study was provided by Pfizer, Inc. The authors declare that they have no financial or non-financial competing interests.